KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash from Financing Activities (2016 - 2025)

Edwards Lifesciences has reported Cash from Financing Activities over the past 17 years, most recently at -$11.4 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$11.4 million for Q4 2025, down 139.86% from a year ago — trailing twelve months through Dec 2025 was -$956.8 million (up 2.67% YoY), and the annual figure for FY2025 was -$956.8 million, up 2.67%.
  • Cash from Financing Activities for Q4 2025 was -$11.4 million at Edwards Lifesciences, up from -$740.1 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for EW hit a ceiling of $61.7 million in Q1 2024 and a floor of -$976.7 million in Q3 2024.
  • Median Cash from Financing Activities over the past 5 years was -$120.0 million (2023), compared with a mean of -$229.6 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 1252.26% in 2022 and later surged 154.55% in 2025.
  • Edwards Lifesciences' Cash from Financing Activities stood at -$62.0 million in 2021, then crashed by 1252.26% to -$838.4 million in 2022, then skyrocketed by 50.72% to -$413.2 million in 2023, then soared by 106.92% to $28.6 million in 2024, then tumbled by 139.86% to -$11.4 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$11.4 million (Q4 2025), -$740.1 million (Q3 2025), and $52.7 million (Q2 2025) per Business Quant data.